S

Springfield Clinic | Clinical Research Department

Research site
(Unclaimed)
Location
900 N First St Rm 1104, Springfield, Illinois, United States of America
Site insights

Top conditions

Carcinoma (54 trials)

Breast Cancer (22 trials)

Lung Cancer (20 trials)

Cancer (18 trials)

Non-Small-Cell Lung Carcinoma (17 trials)

Top treatments

Nivolumab
Atezolizumab
Cisplatin
Paclitaxel
Carboplatin
Pembrolizumab
Palbociclib
Olaparib
Docetaxel
Cabozantinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 142
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy (SKYSCRAPER-15)

The purpose of this study is to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administere...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Drug: Atezolizumab
Drug: Placebo
Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor,...

Enrolling
Non Small Cell Lung Cancer
Biological: Telisotuzumab Vedotin
Drug: Docetaxel

The primary objective of this study is to evaluate the effect of setanaxib on alkaline phosphatase (ALP) at Week 24 in participants with PBC and with...

Active, not recruiting
Liver Stiffness
Primary Biliary Cholangitis
Drug: Placebo
Drug: Setanaxib

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor D...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 6 month
Drug: mFOLFOX6 3-6 month

This is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effect...

Enrolling
Diabetes
Device: Blood glucose meter
Device: Eversense CGM System

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in pa...

Enrolling
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Other: Questionnaire Administration
Other: Quality-of-Life Assessment

This phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy...

Active, not recruiting
Recurrent Primary Peritoneal Carcinoma
Ovarian Undifferentiated Carcinoma
Drug: Gemcitabine
Drug: Cediranib Maleate

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with me...

Enrolling
Recurrent Meningioma
NF2 Gene Mutation
Drug: Abemaciclib
Drug: Vismodegib

Trial sponsors

National Cancer Institute (NCI) logo

National Cancer Institute (NCI) (101 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems